Clinical Trials Collective Data Environment 
Cannabis Law Report
JULY 28, 2021
MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. The RPS must enjoy working within a small, entrepreneurial environment in which the ability to work under pressure and to handle a wide variety of activities is necessary. Experience working for a clinical study Sponsor.
Cannabis Law Report
FEBRUARY 5, 2022
Support new product development and further clinical activities. Review clinical protocols to ensure the collection of data needed for regulatory submissions. Experience with prescription drug registration submissions and lifecycle management, including clinical trial activities. SKILLS/QUALIFICATIONS.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
AUGUST 11, 2021
Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”. We overcame significant regulatory obstacles obstructing cannabis research to conduct the first clinical trial of inhaled cannabis for PTSD ,” said Yazar-Klosinki. .
Cannabis Law Report
DECEMBER 15, 2021
Support new product development and further clinical activities. Review clinical protocols to ensure the collection of data needed for regulatory submissions. Experience with prescription drug registration submissions and lifecycle management, including clinical trial activities. SKILLS/QUALIFICATIONS.
Cannabis Law Report
AUGUST 3, 2021
Testing under the Contract will commence in early August 2021, and all sample collection sites will be fully operational before the start of the academic year on August 25. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.
Cannabis Law Report
JUNE 2, 2021
Samples will be collected via anterior nasal swabs that offer ease-of-use for all ages. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Food and Drug Administration (U.S.
Cannabis Law Report
FEBRUARY 2, 2022
– Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA). Dr. Manalo-Morgan has spent the last 5 years researching cannabis and has specialized in the formulation of cannabinoid products for clinical trials.
Expert insights. Personalized for you.
105 
Let's personalize your content